Lv65
2320 积分 2023-07-25 加入
Evolving Strategies for Target Selection for Antibody-Drug Conjugates
1个月前
已完结
Immunotherapy plus chemoradiotherapy in cervical cancer management
1个月前
已完结
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
2个月前
已完结
Stromal biology and therapy in pancreatic cancer
2个月前
已完结
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma
2个月前
已完结
Combinatorial strategies to target RAS-driven cancers
3个月前
已完结
Outcomes of first-line immune checkpoint inhibitors with or without chemotherapy according to KRAS mutational status and PD-L1 expression in patients with advanced NSCLC: FDA pooled analysis
3个月前
已完结
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment
3个月前
已完结
Deep whole-genome analysis of 494 hepatocellular carcinomas
3个月前
已完结
A classical epithelial state drives acute resistance to KRAS inhibition in pancreas cancer
3个月前
已完结
皖公网安备34019202002308
